Leaders in academic, clinical, and industry research gather to explore the interconnected spectrum of metabolic diseases
San Diego, November 11, 2023 — ProSciento, Inc., a leading clinical research organization specializing in metabolic diseases, proudly hosted the 7th Metabolic Continuum Roundtable Forum on November 10, 2023, in Boston, Massachusetts. Managed by ProSciento, the Metabolic Continuum Roundtable is an annual forum that brings together an international network of thought leaders to drive cross-disciplinary dialogue on scientific advancements and clinical strategies across the metabolic disease spectrum.
The theme of the 2023 forum was:
Steatotic Liver Disease (MASLD/MASH): Disease Burden – Patient Reported Outcomes – Health Economics: Payor & Societal Perspectives.
This focused, one-day forum convened more than 20 global experts in academic research, clinical care, health economics, and biopharmaceutical innovation to discuss pressing questions around the burden of metabolic dysfunction–associated steatotic liver disease (MASLD) and steatohepatitis (MASH), with an emphasis on real-world outcomes, patient perspectives, and economic implications for healthcare systems and society.
This year’s forum was moderated by:
- Rohit Loomba, MD, MHSc
Professor of Medicine, Chief, Division of Gastroenterology and Hepatology, University of California San Diego; Director, MASLD Research Center - Arun J. Sanyal, MD
Z. Reno Vlahcevic Research Professor in Gastroenterology Research; Professor at Virginia Commonwealth University School of Medicine
Keynote presentations were delivered by:
- Zobair Younossi, MD
Chairman and Professor of Medicine, Inova Fairfax Medical Campus - Homie Razavi, PhD, MBA
Managing Director, Center for Disease Analysis Foundation - Michael Sherman, MD, MBA, MS
Venture Partner, RA Capital Management, L.P.
“The Metabolic Continuum Roundtable was founded on the belief that meaningful progress in this field depends on collaborative thinking across disciplines,” said Dr. Marcus Hompesch, CEO of ProSciento and Chair of the Roundtable’s organizing body. “As the understanding of steatotic liver diseases evolves, it is critical that we examine not only the clinical and scientific aspects, but also how these conditions impact patients’ lives and the healthcare systems that support them.”
The Roundtable is a non-promotional, invitation-only forum designed to foster open, solution-oriented discussions free from commercial influence. It serves as a unique platform for scientific exchange, strategic alignment, and advancement of clinical development initiatives across the metabolic disease continuum.
More information about the Roundtable and this year’s agenda and participants is available at: www.metabolic-continuum-roundtable.com/7th-forum
To learn more about ProSciento and its leadership in metabolic clinical research, visit prosciento.com.